Pioneer Hi-Bred International, Inc.: Private Company Information - Bloomberg
Food Products
Company Overview of Pioneer Hi-Bred International, Inc.
Snapshot
People
Company Overview
- Pioneer Hi-Bred International, Inc. produces and supplies plant genetics, and produces seeds.
- Its products include crops, such as alfalfa, canola, corn and maize, cotton, inoculants, mustard, pearl millet, rice, sorghum, soybeans, sunflowers, and wheat.
- It also provides agronomic support and services to help increase yield and profitability for farmers.
- Pioneer Hi-Bred International, Inc. was formerly known as Hi-Bred Corn Company and changed its name to Pioneer Hi-Bred International, Inc. in 1970. The company was founded in 1926 and is based in Johnston, Iowa. Pioneer Hi-Bred International, Inc. operates as a subsidiary of DowDuPont Inc.
7100 NW 62nd Avenue
PO Box 1150
Johnston, IA 50131
United States
Founded in 1926
5,025 Employees
Phone:
888-444-2733
Fax:
515-253-5789
www.pioneer.com
Key Executives For Pioneer Hi-Bred International, Inc.
Mr. Timothy Johnson
Finance Director
Mr. Cornel B. Fuerer
Associate General Counsel
Mr. Michael Patrick
Director of Human Resources
Mr. Jeffrey L. Burnison
Commercial Lead - PROaccess
Compensation as of Fiscal Year 2018.
Pioneer Hi-Bred International, Inc. Key Developments
Dupont Pioneer and Broad Institute of MIT and Harvard Join Forces to Enable Democratic Access to Crispr Licensing in Agriculture
Oct 18 17
---------------
DuPont Pioneer and the Broad Institute of MIT and Harvard announced that they have reached an agreement to jointly provide non-exclusive licenses to foundational CRISPR-Cas9 intellectual property under their respective control for use in commercial agricultural research and product development. These two major CRISPR-Cas9 license holders are coming together with the shared goal of enabling all entities wanting to apply the technology for agricultural applications with a full range of CRISPR-Cas9 tools. Such foundational intellectual property (IP) for CRISPR-Cas9 technology will be freely available to universities and nonprofit organizations for academic research. Pioneer is a business unit of the Agriculture Division of DowDuPont™.
Oct 18 17
---------------
DuPont Pioneer and the Broad Institute of MIT and Harvard announced that they have reached an agreement to jointly provide non-exclusive licenses to foundational CRISPR-Cas9 intellectual property under their respective control for use in commercial agricultural research and product development. These two major CRISPR-Cas9 license holders are coming together with the shared goal of enabling all entities wanting to apply the technology for agricultural applications with a full range of CRISPR-Cas9 tools. Such foundational intellectual property (IP) for CRISPR-Cas9 technology will be freely available to universities and nonprofit organizations for academic research. Pioneer is a business unit of the Agriculture Division of DowDuPont™.
---
DuPont Pioneer and Evogene Ltd. Announce Multiyear Research Collaboration for Development of Corn Bio-Stimulant Products
Jul 26 17
DuPont Pioneer (DuPont) and Evogene Ltd. announced that they have entered into a multiyear collaboration. The scope of the agreement includes the research and development of microbiome-based seed treatments in corn. The goal of the collaboration is to provide farmers with innovative bio-stimulant seed treatment products that protect and maximize corn yield by leveraging each other’s relevant market-leading technologies. Under the terms of the agreement, DuPont will provide access to its extensive seed treatment application technology and product development expertise.
Evogene will apply its predictive computational biology platform to decipher plant/microbiome interactions along with its microbial formulation and fermentation technologies. The combination of these key capabilities increases the opportunity to fully activate the potential of the emerging field of microbiome-based seed treatment products. Ag-biologicals represent a growing approach for driving agriculture productivity and are increasingly adopted by farmers to complement the existing solutions of improved seed traits and crop protection chemistry. The bio-stimulant market is an evolving segment with immense potential and estimated by Markets and Markets™ in 2016 at over $1.6 billion with a projected annual growth rate of approximately 10 percent. Microbiomes are microbial communities that reside on or within the plant's immediate microbial environment and play a significant role in plant health. Bio-stimulants are agricultural biologic products, which increase crop yield and resilience to environmental (abiotic) stress by enhancing desirable plant characteristics and promoting efficient use of nutrient inputs. By leveraging the understanding of the complex plant/microbiome interaction, the parties will work to develop a next generation of bio-stimulant products aimed at demonstrating high standards for performance and consistency criteria across a range of corn varieties and global locations. Product development efforts under the collaboration will utilize, as a starting point, Evogene’s proprietary microbe combinations which are already identified and validated in field testing to have significant positive impact on key crop characteristics, including yield productivity as previously disclosed by Evogene in 2016. The multi-year collaboration has an extension option if certain milestones are met. Pioneer will obtain worldwide marketing rights for any products, with milestone payments and royalties to be paid to Evogene.
DuPont Pioneer and Evogene Ltd. Announce Multiyear Research Collaboration for Development of Corn Bio-Stimulant Products
Jul 26 17
DuPont Pioneer (DuPont) and Evogene Ltd. announced that they have entered into a multiyear collaboration. The scope of the agreement includes the research and development of microbiome-based seed treatments in corn. The goal of the collaboration is to provide farmers with innovative bio-stimulant seed treatment products that protect and maximize corn yield by leveraging each other’s relevant market-leading technologies. Under the terms of the agreement, DuPont will provide access to its extensive seed treatment application technology and product development expertise.
Evogene will apply its predictive computational biology platform to decipher plant/microbiome interactions along with its microbial formulation and fermentation technologies. The combination of these key capabilities increases the opportunity to fully activate the potential of the emerging field of microbiome-based seed treatment products. Ag-biologicals represent a growing approach for driving agriculture productivity and are increasingly adopted by farmers to complement the existing solutions of improved seed traits and crop protection chemistry. The bio-stimulant market is an evolving segment with immense potential and estimated by Markets and Markets™ in 2016 at over $1.6 billion with a projected annual growth rate of approximately 10 percent. Microbiomes are microbial communities that reside on or within the plant's immediate microbial environment and play a significant role in plant health. Bio-stimulants are agricultural biologic products, which increase crop yield and resilience to environmental (abiotic) stress by enhancing desirable plant characteristics and promoting efficient use of nutrient inputs. By leveraging the understanding of the complex plant/microbiome interaction, the parties will work to develop a next generation of bio-stimulant products aimed at demonstrating high standards for performance and consistency criteria across a range of corn varieties and global locations. Product development efforts under the collaboration will utilize, as a starting point, Evogene’s proprietary microbe combinations which are already identified and validated in field testing to have significant positive impact on key crop characteristics, including yield productivity as previously disclosed by Evogene in 2016. The multi-year collaboration has an extension option if certain milestones are met. Pioneer will obtain worldwide marketing rights for any products, with milestone payments and royalties to be paid to Evogene.
No comments:
Post a Comment